96 related articles for article (PubMed ID: 20210135)
1. [The distribution analysis of the biomarkers on breast cancer tissues by Hadamard transform spectral microscopic imaging].
Xu H; Chen C; Liu CM; Peng J; Li Y; Zhang ZL; Tang HW
Guang Pu Xue Yu Guang Pu Fen Xi; 2009 Dec; 29(12):3216-9. PubMed ID: 20210135
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cancer marker in tissues with Hadamard transform fluorescence spectral microscopic imaging.
Xu H; Chen C; He Y; Tang HW; Zhang ZL; Li Y; Pang DW
J Fluoresc; 2015 Mar; 25(2):397-402. PubMed ID: 25663197
[TBL] [Abstract][Full Text] [Related]
3. Hadamard transform spectral microscopy for single cell imaging using organic and quantum dot fluorescent probes.
Xu H; Peng J; Tang HW; Li Y; Wu QS; Zhang ZL; Zhou G; Chen C; Li Y
Analyst; 2009 Mar; 134(3):504-11. PubMed ID: 19238287
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the bioconjugation efficiency of different quantum dots as probes for immunostaining tumor-marker proteins.
Xu H; Chen C; Peng J; Tang HW; Liu CM; He Y; Chen ZZ; Li Y; Zhang ZL; Pang DW
Appl Spectrosc; 2010 Aug; 64(8):847-52. PubMed ID: 20719046
[TBL] [Abstract][Full Text] [Related]
5. Accurate sensitivity of quantum dots for detection of HER2 expression in breast cancer cells and tissues.
Tabatabaei-Panah AS; Jeddi-Tehrani M; Ghods R; Akhondi MM; Mojtabavi N; Mahmoudi AR; Mirzadegan E; Shojaeian S; Zarnani AH
J Fluoresc; 2013 Mar; 23(2):293-302. PubMed ID: 23212129
[TBL] [Abstract][Full Text] [Related]
6. In situ spectral imaging of marker proteins in gastric cancer with near-infrared and visible quantum dots probes.
He Y; Xu H; Chen C; Peng J; Tang H; Zhang Z; Li Y; Pang D
Talanta; 2011 Jul; 85(1):136-41. PubMed ID: 21645682
[TBL] [Abstract][Full Text] [Related]
7. Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization.
Annaratone L; Simonetti M; Wernersson E; Marchiò C; Garnerone S; Scalzo MS; Bienko M; Chiarle R; Sapino A; Crosetto N
Oncotarget; 2017 Mar; 8(12):18680-18698. PubMed ID: 28423635
[TBL] [Abstract][Full Text] [Related]
8. Impact of estrogen receptor (ER) and human epidermal growth factor receptor-2 (HER2) co-expression on breast cancer disease characteristics: implications for tumor biology and research.
Alqaisi A; Chen L; Romond E; Chambers M; Stevens M; Pasley G; Awasthi M; Massarweh S
Breast Cancer Res Treat; 2014 Nov; 148(2):437-44. PubMed ID: 25257728
[TBL] [Abstract][Full Text] [Related]
9. Quantitative diagnosis of HER2 protein expressing breast cancer by single-particle quantum dot imaging.
Miyashita M; Gonda K; Tada H; Watanabe M; Kitamura N; Kamei T; Sasano H; Ishida T; Ohuchi N
Cancer Med; 2016 Oct; 5(10):2813-2824. PubMed ID: 27666577
[TBL] [Abstract][Full Text] [Related]
10. Passive and active targeting of quantum dots for whole-body fluorescence imaging of breast cancer xenografts.
Balalaeva IV; Zdobnova TA; Krutova IV; Brilkina AA; Lebedenko EN; Deyev SM
J Biophotonics; 2012 Nov; 5(11-12):860-7. PubMed ID: 22887708
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
[TBL] [Abstract][Full Text] [Related]
12. Small-Protein-Stabilized Semiconductor Nanoprobe for Targeted Imaging of Cancer Cells.
Zhao N; Liu S; Jiang Q; Lan T; Cheng Z; Liu H
Chembiochem; 2016 Jul; 17(13):1202-6. PubMed ID: 27123671
[TBL] [Abstract][Full Text] [Related]
13. Quantum dot bioconjugates for in vitro diagnostics & in vivo imaging.
Xing Y; Rao J
Cancer Biomark; 2008; 4(6):307-19. PubMed ID: 19126959
[TBL] [Abstract][Full Text] [Related]
14. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots.
Wu X; Liu H; Liu J; Haley KN; Treadway JA; Larson JP; Ge N; Peale F; Bruchez MP
Nat Biotechnol; 2003 Jan; 21(1):41-6. PubMed ID: 12459735
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Wilms' tumor 1 isoforms with HER2 and ER-α and its oncogenic role in breast cancer.
Nasomyon T; Samphao S; Sangkhathat S; Mahattanobon S; Graidist P
Anticancer Res; 2014 Mar; 34(3):1333-42. PubMed ID: 24596380
[TBL] [Abstract][Full Text] [Related]
16. [Expression of estrogen receptor, progesterone receptor, and human epithelial growth factor receptor 2 in breast cancer and the significance thereof: analysis of 910 cases].
Liu RB; Zhou XH; Wang JN; Liang HZ; Li XX; Wu ZH; Ye JL; Wang SM
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3397-400. PubMed ID: 19159568
[TBL] [Abstract][Full Text] [Related]
17. Peptide-functionalized ZCIS QDs as fluorescent nanoprobe for targeted HER2-positive breast cancer cells imaging.
Michalska M; Florczak A; Dams-Kozlowska H; Gapinski J; Jurga S; Schneider R
Acta Biomater; 2016 Apr; 35():293-304. PubMed ID: 26850146
[TBL] [Abstract][Full Text] [Related]
18. Hormone receptor and HER2 assessment in breast carcinoma metastatic to bone: A comparison between FNA cell blocks and decalcified core needle biopsies.
Zeng J; Piscuoglio S; Aggarwal G; Magda J; Friedlander MA; Murray M; Akram M; Reis-Filho JS; Weigelt B; Edelweiss M
Cancer Cytopathol; 2020 Feb; 128(2):133-145. PubMed ID: 31883437
[TBL] [Abstract][Full Text] [Related]
19. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
[TBL] [Abstract][Full Text] [Related]
20. Predictive diagnosis of the risk of breast cancer recurrence after surgery by single-particle quantum dot imaging.
Gonda K; Miyashita M; Higuchi H; Tada H; Watanabe TM; Watanabe M; Ishida T; Ohuchi N
Sci Rep; 2015 Sep; 5():14322. PubMed ID: 26392299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
